JPH0149299B2 - - Google Patents

Info

Publication number
JPH0149299B2
JPH0149299B2 JP58032956A JP3295683A JPH0149299B2 JP H0149299 B2 JPH0149299 B2 JP H0149299B2 JP 58032956 A JP58032956 A JP 58032956A JP 3295683 A JP3295683 A JP 3295683A JP H0149299 B2 JPH0149299 B2 JP H0149299B2
Authority
JP
Japan
Prior art keywords
formula
group
represented
polymer
mol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP58032956A
Other languages
Japanese (ja)
Other versions
JPS59159828A (en
Inventor
Yoshinori Kato
Takeshi Hara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teijin Ltd
Original Assignee
Teijin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teijin Ltd filed Critical Teijin Ltd
Priority to JP3295683A priority Critical patent/JPS59159828A/en
Publication of JPS59159828A publication Critical patent/JPS59159828A/en
Publication of JPH0149299B2 publication Critical patent/JPH0149299B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Polyamides (AREA)

Description

【発明の詳现な説明】[Detailed description of the invention]

 産業䞊の利甚分野 本発明は、偎鎖に倚数のカルボキシル基又は
その塩を有するず共に、䞻鎖の片末端にチオヌ
ル基を含む掻性基を有する、反応性に富んだ重合
䜓の補造法に関する。そしお、本発明の目的ずす
るずころは、腫瘍现胞等の暙的物に結合胜を有す
る抗腫瘍抗䜓等ず、制ガン剀等の现胞毒物を結合
しお暙的指向型制ガン剀抗腫瘍剀等を補造す
るに際し、䞡者を有効か぀効率良く結合させるた
めに甚いるこずができる重合䜓を提䟛するこずに
ある。  埓来技術 ある皮の现胞だけを遞択的に殺すこずを目的ず
しお、その暙的现胞ず特異的に結合しうる免疫グ
ロブリンを皮々の现胞毒性物質ず結合させる詊み
がなされおきた。䟋えば、免疫グロブリンに−
ビス−クロロ゚チルアミノ−−プニル
アラニン等を結合した耇合䜓特開昭51−61640
号、免疫グロブリンにメトトレキセヌト等を結
合した耇合䜓特開昭56−65829号、免疫グロブ
リンにクロラムブシル等を結合した耇合䜓特開
昭56−65829号、免疫グロブリンにマむトマむシ
ン−等を結合した耇合䜓特開昭55−92325
号、免疫グロブリンにダりノマむシンを結合し
た耇合䜓特開昭51−144723号等が公知であ
る。 曎に、特開昭51−126281号には、抗腫瘍免疫グ
ロブリンず、分子圓り制ガン剀を〜500分子
共有結合しおいる重合䜓担䜓䟋えば、ポリダル
タミン酞を、アミド結合によ぀お結合させお抗
腫瘍剀を埗たこずが開瀺されおいる。 これらの方法で埗られた现胞毒性耇合䜓は、腫
瘍现胞ず遞択的に結合した腫瘍现胞に毒性を発揮
するこずが期埅されるものであり、非垞に興味の
ある薬剀である。しかしながら现胞毒性物質を盎
接免疫グロブリンに結合する堎合は、免疫グロブ
リンに倚数の现胞毒性物質を結合するず、免疫グ
ロブリンの抗原認識掻性が䜎䞋しおしたうので、
かゝる困難を回避するためには、少数の现胞毒性
物質を結合するにずどめざるをえない。 䞀方、重合䜓を现胞毒性物質の担䜓ずしお甚い
る堎合は、䞊蚘の難点を改善するこずができるず
考えられる。しかし、特開昭51−126281号蚘茉の
方法は、重合䜓担䜓に倚数の现胞毒性物質を結合
する反応ず、重合䜓−制ガン剀結合䜓に免疫グロ
ブリンを結合する反応が同䞀な反応のため、倚数
の免疫グロブリンが重合䜓担䜓に結合しおした
い、そのため埗られる耇合䜓が均䞀なものずなり
埗ないのみならず、治療剀ずしお甚いるのが䞍適
圓な高分子量物質も含む、ずい぀た問題を生じる
のである。  発明の目的 本発明者等は、かかる先行技術の欠点を解決す
べく鋭意研究を行぀た結果、免疫グロブリンずの
結合反応に䟛する反応基をコだけ含有し、か
぀、それずは異なる、现胞毒性物質を結合するた
めの、反応基を倚数含む重合䜓担䜓を甚意し、先
ず倚数の反応基によ぀お倚数の现胞毒性物質を該
重合䜓担䜓に結合した埌に、免疫グロブリンずの
反応基によ぀お免疫グロブリンず結合する、ずい
う手順を螏むこずによれば、治療剀ずしお甚いる
のが䞍適圓な高分子物質を含たず、か぀、倚数の
现胞毒性物質を結合した免疫グロブリン−现胞毒
性物質耇合䜓を補造し埗るこずを芋い出した。そ
しお本発明は、かかる抗腫瘍剀あるいは又その他
の暙的指向型薬剀を補造する際に最適に䜿甚でき
る、反応性重合䜓を提䟛するものである。  発明の構成及び䜜甚 本発明は構成単䜍の60モル以䞊が匏〔〕で
衚わされる構成単䜍からなり、 〔匏〔〕においお、は氎玠原子又は䟡の
陜むオンを衚わす。は−の敎数を衚わす。〕 匏の構成単䜍が100モルでないずき、
残りの構成単䜍は匏′ 〔匏′においお、は−−CH3
a Industrial Application Field The present invention is directed to the production of highly reactive polymers that have a large number of carboxyl groups (or salts thereof) in their side chains and an active group containing a thiol group at one end of the main chain. Regarding the law. The purpose of the present invention is to manufacture target-directed anti-cancer drugs (anti-tumor drugs) by combining anti-tumor antibodies, etc. that have the ability to bind to targets such as tumor cells, and cytotoxic substances, such as anti-cancer drugs. The object of the present invention is to provide a polymer that can be used to effectively and efficiently bind the two. b. Prior Art For the purpose of selectively killing only certain types of cells, attempts have been made to combine various cytotoxic substances with immunoglobulins that can specifically bind to the target cells. For example, p-
Complex containing bis(2-chloroethyl)amino-L-phenylalanine, etc. (Japanese Patent Application Laid-open No. 51-61640
), a complex in which immunoglobulin is bound to methotrexate, etc. (JP-A-56-65829), a complex in which immunoglobulin is bound to chlorambucil, etc. (JP-A-56-65829), immunoglobulin and mitomycin-C, etc. A complex combining (JP-A-55-92325
(No. 1987), a complex in which daunomycin is bound to immunoglobulin (Japanese Patent Application Laid-open No. 144723/1983), and the like are known. Furthermore, JP-A-51-126281 discloses a method in which an antitumor immunoglobulin and a polymer carrier (e.g., polydaltamic acid) to which 5 to 500 anticancer drug molecules are covalently bonded per molecule are bonded through an amide bond. It is disclosed that an antitumor agent was obtained by using The cytotoxic complexes obtained by these methods are expected to exert toxicity on tumor cells to which they have selectively bound, and are thus very interesting drugs. However, when a cytotoxic substance is directly bound to an immunoglobulin, the antigen recognition activity of the immunoglobulin decreases when a large number of cytotoxic substances are bound to the immunoglobulin.
In order to avoid such difficulties, it is necessary to bind only a small number of cytotoxic substances. On the other hand, when a polymer is used as a carrier for a cytotoxic substance, it is thought that the above-mentioned difficulties can be improved. However, in the method described in JP-A-51-126281, the reaction of binding a large number of cytotoxic substances to a polymer carrier and the reaction of binding an immunoglobulin to a polymer-anticancer drug conjugate are the same reaction. of the immunoglobulin binds to the polymeric carrier, leading to problems such as the resulting complex not only being non-uniform but also containing high molecular weight substances that are unsuitable for use as a therapeutic agent. It is. c. Purpose of the Invention As a result of intensive research to solve the drawbacks of the prior art, the present inventors have discovered that a cell that contains only one reactive group for binding reaction with immunoglobulin and that is different from that reactive group. A polymer carrier containing a large number of reactive groups for binding a toxic substance is prepared, and after first binding a large number of cytotoxic substances to the polymer carrier through the multiple reactive groups, the reactive group with the immunoglobulin is bonded to the polymer carrier. Therefore, by following the procedure of binding with immunoglobulin, an immunoglobulin-cytotoxic substance complex that does not contain polymeric substances unsuitable for use as a therapeutic agent and binds a large number of cytotoxic substances can be obtained. discovered that it is possible to manufacture the body. The present invention provides a reactive polymer that can be optimally used in the production of such antitumor agents or other target-directed drugs. d Structure and operation of the invention In the present invention, 60 mol% or more of the structural units consist of structural units represented by the formula [], In [Formula [], Z represents a hydrogen atom or a monovalent cation. m represents an integer of 1-4. ] When the constituent units of formula [] are not 100 mol%,
The remaining structural units are the formula [′] [In formula ['], R is -H, -CH 3 ,

【匏】たたは−CH2OHで衚わされ る基である。〕 で衚わされる構成単䜍からなり、そしお䞻鎖のア
ミノ末端に匏−で衚わされる掻性基を有
しおいる、 〔匏−においお、は炭玠数〜のア
ルキレン基を衚わす。 重合床が〜3000の反応性重合䜓の補造法であ
る。 本発明の反応重合䜓は、偎鎖に存圚する倚数の
カルボキシル基又はその塩を利甚しお、これ
に制ガン剀等の现胞毒物を結合するこずが出来、
たた䞻鎖の片末端に存圚する掻性基を利甚しお、
これに抗腫瘍抗䜓等の免疫グロブリンを結合する
こずが出来るものである。 匏〔〕においお、は氎玠原子又は䟡の陜
むオン、䟋えばNa+K+NH4 +である。は
〜の敎数を衚わすが、奜たしいのはが又は
の堎合である。なお、本発明の反応性重合䜓䞭
には、匏〔〕で衚わされる構成単䜍のうち、䟋
えばのものずのものが混圚しおいお
も良い。これらが合蚈で、党構成単䜍のうちの60
モル以䞊、奜たしくは80モル以䞊あればよい
のである。 本発明の反応性重合䜓䞭には、党構成単䜍の40
モル未満の範囲で、匏〔〕で衚わされる構成
単䜍以倖の構成単䜍が含たれおいおもよい。これ
らの䟋ずしおは、䟋えばα䜍偎鎖にカルボキシル
基又はその塩を有しないグリシン、アラニ
ン、プニルアラニン、セリン等のα−アミノ酞
がある。 かかるα−アミノ酞からなる構成単䜍は、现胞
毒物ずの結合には䜕ら関䞎しないが、反応性重合
䜓の氎溶性や现胞毒物を結合しお埗られた重合䜓
の脂溶性や氎溶性を調節するのに圹立぀堎合があ
る。埓぀お、脂溶性や氎溶性の調節が栌別に必芁
ない堎合には、かかるα−アミノ酞からなる構成
単䜍を含有しないものの方が実甚的に有利であ
る。 匏〔〕においお、は氎玠原子又は隣りの硫
黄原子ず共に掻性ゞスルフむド結合を圢成しうる
基を衚わすが、埌者ずしおは、䟋えば−ビリゞ
ルチオ基
It is a group represented by [Formula] or -CH 2 OH. ] Consisting of a structural unit represented by the following, and having an active group represented by the formula [-a] at the amino terminal of the main chain, In [Formula-a], W represents an alkylene group having 1 to 4 carbon atoms. This is a method for producing a reactive polymer having a degree of polymerization of 5 to 3,000. The reactive polymer of the present invention can bind cytotoxic substances such as anticancer drugs to it by utilizing a large number of carboxyl groups (or salts thereof) present in the side chains.
In addition, by utilizing the active group present at one end of the main chain,
Immunoglobulins such as anti-tumor antibodies can be bound to this. In formula [], Z is a hydrogen atom or a monovalent cation, such as Na + , K + , NH 4 + . m is 1
It represents an integer of ~4, but m is preferably 1 or 2. In addition, in the reactive polymer of the present invention, among the structural units represented by the formula [], for example, those in which m=1 and those in which m=2 may be mixed. These total 60 of the total constituent units.
It is sufficient if it is at least 80 mol%, preferably at least 80 mol%. In the reactive polymer of the present invention, 40
Constituent units other than those represented by the formula [] may be contained within a range of less than mol%. Examples of these include α-amino acids, such as glycine, alanine, phenylalanine, and serine, which do not have a carboxyl group (or a salt thereof) in the α-position side chain. Such a structural unit consisting of an α-amino acid does not participate in any way in binding with a cytotoxic substance, but it regulates the water solubility of the reactive polymer and the lipid solubility and water solubility of the polymer obtained by binding the cytotoxic substance. It may be helpful. Therefore, if there is no particular need to adjust fat solubility or water solubility, it is practically advantageous to use a product that does not contain such a constituent unit consisting of an α-amino acid. In formula [], X represents a hydrogen atom or a group capable of forming an active disulfide bond with an adjacent sulfur atom, and the latter is, for example, a 2-pyridylthio group.

【匏】−ピリゞルチオ基[Formula] 4-pyridylthio group

【匏】−カルボキシ−−ニトロ プニルチオ基[Formula] 3-carboxy-4-nitro phenylthio group

【匏】−カル ボキシ−−ピリゞルチオ基
[Formula] 4-carboxy-2-pyridylthio group

【匏】−オキシ−−ピ リゞルチオ基[Formula] N-oxy-2-pi Lysylthio group

【匏】−ニトロプ ニルチオ基[Formula] 2-nitrophe Nylthio group

【匏】−ニトロ−− ピリゞルチオ基[Formula] 4-nitro-2- Pyridylthio group

【匏】−ベン ゟチアゟむルチオ基[Formula] 2-ben Zothiazoylthio group

【匏】− ベンゟむミダゟむルチオ基
[Formula] 2-benzimidazoylthio group

【匏】及び−プニルアミノ −N′−プニルむミノメチルチオ基
[Formula] and N-phenylamino-N'-phenyliminomethylthio group

【匏】がある。 匏〔〕においおは䟡の有機基を衚わし、
本発明の反応性重合䜓を埗る過皋及びその埌の反
応過皋で䜕ら反応に関䞎しない䞍掻性な基である
限り特に限定されない。これらの基ずしおは、䟋
えば、−アミノプロピオン酞残基−CH2CH2
−の劂き盎鎖の、あるいは−ペンゟむルシス
テむン残基
There is a [formula]. In formula [], W represents a divalent organic group,
It is not particularly limited as long as it is an inert group that does not participate in any reaction during the process of obtaining the reactive polymer of the present invention and the subsequent reaction process. These groups include, for example, 2-aminopropionic acid residue (-CH 2 CH 2
-) or N-penzoylcysteine residues such as

【匏】や−アチル ホモシステむン残基[Formula] and N-acyl homocysteine residue

【匏】やメル カプトコハク酞残基【Formula】Yamel Captosuccinic acid residue

【匏】の劂き偎 鎖眮換基を有するアルキレン基、−メルカプト
安息銙酞残基
Alkylene group having a side chain substituent as shown in [Formula], 4-mercaptobenzoic acid residue

【匏】の劂き眮換基を有 しない、あるいは眮換基を有するプニレン基が
挙げられるが、炭玠数〜のアルキレン基が特
に奜たしい。 本発明の反応性重合䜓のうち、匏〔〕におけ
るは氎玠原子であるもの、即ち、䞻鎖のアミノ
末端に䞋蚘匏〔−〕 〔匏〔−〕においお、の定矩は匏〔〕
の堎合ず同じ。〕 で衚わされる掻性基を有しおいる反応性重合䜓を
補造する方法に぀いお説明する。 その方法は、構成単䜍の60モル以䞊が前蚘匏
〔〕で衚わされる構成単䜍からなり、重合床が
〜3000の芪氎性重合䜓に、匏〔〕 R1S−−CO−R2  〔〕 〔匏䞭、の定矩は匏〔〕の堎合ず同じであ
る。R1はチオヌル基の保護基を衚わす。R2は隣
接するカルボニル基を掻性化し埗る基を衚わす。〕 で衚わされる保護されたチオヌル基を含有するア
シル化剀を反応せしめ、重合䜓のアミノ末端をア
シル化し、次いで又は同時にチオヌル基の保
護基を陀去するこずにより目的ずする反応性重合
䜓を補造する方法である。 本方法で䜿甚される原料である、構成単䜍の60
モル以䞊が匏〔〕で衚わされる構成単䜍から
にり、重合床が〜3000の芪氎性重合䜓ずは、䟋
えば匏〔〕においおの堎合に盞圓するポ
リアスパラギン酞、の堎合に盞圓するポリ
グルタミン酞、さらにアスパラギン酞ずグルタミ
ン酞の共重合物や、匏〔〕で衚わすこずができ
ない単䜍構造を有する成分ずしお、䟋えばアラニ
ンの構成単䜍を40モル以内で含有するアスパラ
ギン酞−アラニン共重合䜓、グルタミン酞−アラ
ニン共重合䜓等の芪氎性重合䜓である。これらの
重合䜓は通垞の方法、䟋えば、アミノ酞の−カ
ルボキシ無氎物を重合反応に付すこずによる方法
で䜜補されたものを甚いるこずができる。具䜓䟋
を挙げれば、γ−ベンゞル−−グルタメヌトを
−カルボキシ無氎物に導き、重合反応に付した
埌にベンゞル基を脱離せしめれば、ポリ−−グ
ルタミン酞を容易に埗るこずができる。 本方法で䜿甚されるもう䞀぀の原料である、匏
〔〕で衚わされる保護されたチオヌル基を含有
するアシル化剀においお、R1は䟋えば隣接する
硫黄原子ず共にゞスルフむドを圢成する基であり
埗る。䟋えば、メチルチオ基CH3S−、プチ
ルチオ基CH3CH2CH2CH2S−等のアルキル
チオ基、γ−サクシンむミゞルオキシカルボニル
プロピオニルチオ基
Phenylene groups having no substituents or having substituents as shown in the formula are exemplified, and alkylene groups having 1 to 4 carbon atoms are particularly preferred. Among the reactive polymers of the present invention, those in which X in the formula [] is a hydrogen atom, that is, those having the following formula [-a] at the amino terminal of the main chain [In formula [-a], the definition of W is formula []
Same as in the case of ] A method for producing a reactive polymer having an active group represented by the following will be explained. In this method, a hydrophilic polymer in which 60 mol % or more of the structural units is composed of the structural units represented by the above formula [] and has a degree of polymerization of 5 to 3000 is added with the formula [] R 1 S-W-CO-R 2 ...[] [In the formula, the definition of W is the same as in the case of the formula []. R 1 represents a protecting group for a thiol group. R 2 represents a group capable of activating an adjacent carbonyl group. ] The desired reactive polymer is produced by reacting with an acylating agent containing a protected thiol group represented by the formula, acylating the amino terminal of the polymer, and then (or simultaneously) removing the protecting group for the thiol group. This is a method of manufacturing. 60 of the constituent units that are the raw materials used in this method
A hydrophilic polymer in which mol% or more is composed of structural units represented by the formula [] and has a degree of polymerization of 5 to 3000 is, for example, polyaspartic acid corresponding to the case where m = 1 in the formula [], m = 2 Polyglutamic acid corresponding to the case of , a copolymer of aspartic acid and glutamic acid, and a component having a unit structure that cannot be expressed by the formula [], such as aspartic acid containing up to 40 mol% of alanine constitutional units. Hydrophilic polymers such as alanine copolymers and glutamic acid-alanine copolymers. These polymers can be prepared by a conventional method, for example, by subjecting N-carboxylic anhydride of an amino acid to a polymerization reaction. To give a specific example, poly-L-glutamic acid can be easily obtained by converting γ-benzyl-L-glutamate into N-carboxyanhydride, subjecting it to a polymerization reaction, and then removing the benzyl group. In the acylating agent containing a protected thiol group represented by the formula [ ], which is another raw material used in the present method, R 1 can be, for example, a group that forms a disulfide with the adjacent sulfur atom. For example, alkylthio groups such as methylthio group (CH 3 S-), butylthio group (CH 3 CH 2 CH 2 CH 2 S-), γ-succinimidyloxycarbonylpropionylthio group

【匏】 のごずき、眮換アルキルチオ基−ピリゞルチオ
基
[Formula] Substituted alkylthio group 2-pyridylthio group

【匏】−カルボキシ−−ニト ロプニルチオ基[Formula] 3-carboxy-4-nito lophenylthio group

【匏】等の掻 性ゞスルフむドを圢成し埗る基等を挙げるこずが
できる。R1は又アセチル基
Examples include groups capable of forming an active disulfide such as [Formula]. R 1 is also an acetyl group

【匏】プロピ オニル基[Formula] Propi onyl group

【匏】のごずきアシル基や、 ベンゞル基An acyl group such as [Formula], benzyl group

【匏】も含む。匏 〔〕で衚わされるアシル化剀においお−R2は隣
接するカルボニル基を掻性化し埗る基を衚わし、
䟋えば、サクシンむミゞルオキシ基
Also includes [formula]. In the acylating agent represented by the formula [], -R 2 represents a group capable of activating the adjacent carbonyl group,
For example, succinimidyloxy group

【匏】パラニトロプノキシ基[Formula] Paranitrophenoxy group

【匏】などの掻性゚ステルのア ルコヌル残基、−ブチルカルボキシ基
Alcohol residue of active ester such as [Formula], t-butylcarboxy group

【匏】む゜ブチルオキシカルボ キシ基[Formula] Isobutyloxycarbo xy group

【匏】のごずき酞無氎物の カルボン酞残基、アゞド基〔−N3〕等が奜たし
く甚いられる基である。匏〔〕で衚わされるア
シル化剀においおは匏〔〕における説明ず同
じである。匏〔〕で衚わされる保護されたチオ
ヌル基を含有するアシル化剀の具䜓䟋を挙げれ
ば、サクシンむミゞル−−ピリゞルゞチオ
プロピオネヌト
Preferably used groups include carboxylic acid residues of acid anhydrides such as [Formula], azide group [-N 3 ], and the like. In the acylating agent represented by the formula [], W is the same as described in the formula []. A specific example of an acylating agent containing a protected thiol group represented by the formula [] is succinimidyl 3-(2-pyridyldithio).
Propionate

【匏】【formula】

【匏】−CH2CH2−[Formula] W=−CH 2 CH 2 −,

【匏】、ゞチオビスサクシンむ ミゞルプロピオネヌト
[Formula]), dithiobis(succinimidylpropionate)

【匏】R1[Formula] (R 1 =

【匏】−CH2CH2−[Formula] W=−CH 2 CH 2 −,

【匏】−ベンゟむルシスチンパ ラニトロプニル゚ステル
[Formula], N-benzoylcystine paranitrophenyl ester

【匏】【formula】

【匏】【formula】

【匏】【formula】

【匏】等を挙げるこずがで き、さらに䟋えば、−アセチルホモシステむン
チオラクトン
For example, N-acetylhomocysteine thiolactone

【匏】のごずき、チオ ヌル基の保護基を衚わすR1、カルボニル基の掻
性化基であるR2が分子内に組み蟌たれおいる化
合物も本方法に䜿甚できる。 本方法の反応に甚いられる芪氎性重合䜓に察し
お甚いる保護されたチオヌル基を含有するアシル
化剀は倍〜100倍圓量、さらに奜たしくは倍
〜100倍圓量を甚いる。甚いる溶媒は緩衡液PH
〜、DMF等、均䞀溶液を圢成する溶媒が奜
たしい。トリ゚チルアミン、炭酞゜ヌダ等の塩基
の存圚䞋で反応をより有利に進めるこずもでき
る。反応枩床は℃〜50℃、奜たしくは℃〜30
℃である。反応時間は時間〜日である。 反応終了埌、反応液が緩衡液の堎合は、塩酞、
硫酞等の酞を加え、反応液PH以䞋ずし、生成し
た、保護されたチオヌル基を有するアシル基をア
ミノ末端に結合した芪氎性重合䜓の沈柱を生じせ
しめ、これを取する方法により、生成物を粟補
する。反応液が氎以倖の溶媒を䜿甚しおいる堎合
は、緩衡液を加えおから、同様の方法により粟補
できる。他に、透析やゲル過により粟補するこ
ずもできる。 しかしお埗られた、保護されたチオヌル基を有
するアシル基をアミノ末端に結合した芪氎性重合
䜓の、チオヌル基の保護基を脱離し、よ぀お目的
物である、䞻鎖のアミノ末端に匏〔−〕で衚
わされる掻性基を有しおいる反応性重合䜓を埗る
方法に぀いお述べる。保護基を脱離する方法は、
保護基の皮類によ぀お異なる。䟋えば、匏〔〕
においおR1が隣接する硫黄原子ず共にゞスルフ
むドを圢成しおいる堎合は、ゞスルフむド基を還
元的に切断する方法が奜たしく甚いられる。䟋え
ば−メルカプト゚タノヌル、ゞチオスレむトヌ
ル、氎玠化ホり玠ナトリりム等の還元剀を氎溶液
䞭、該芪氎性重合䜓に䜜甚するこずによ぀お、こ
れをチオヌル含有基をアミノ末端に有する反応性
重合䜓に導くこずができる。甚いる還元剀の量は
〜100圓量が奜たしい。反応枩床は℃〜50℃、
反応時間は分〜時間が奜たしい。匏〔〕に
おいお、R1がアシル基の堎合は、加氎分解によ
りこれを脱離する。反応は氎溶液䞭、觊媒ずしお
ヒドロキシルアミン、炭酞ナトリりム、氎酞化ナ
トリりム等のアルカリを〜100圓量甚いおおこ
なう。反応枩床は〜50℃、反応時間は10分〜10
時間が奜たしい。匏〔〕においおR1がベンゞ
ル基の堎合は、過剰のトリフルオロ酢酞やメタン
スルホン酞又はそれらの混合液で該芪氎性重合䜓
を凊理する。反応枩床は℃〜30℃、反応時間は
30分〜10時間である。なお、匏〔〕で衚わされ
る保護されたチオヌル基を含有するアシル化剀ず
しお䟋えば−アセチルホモシステむンチオラク
トンを甚いる堎合はアシル化反応ず同時に脱保護
基反応が進むため、重ねお脱保護基反応を行なう
必芁は無い。 かくしお埗られた、䞻鎖のアミノ末端に匏〔
−〕で衚わされる掻性基を有しおいる反応性重
合䜓は、䞍玔物ずしお䜎分子物質は含有しおいな
いが、しかし、原料ずしお甚いた芪氎性重合䜓の
䞀郚を末反応のたた含有しおいる可胜性がある。 次に、この未反応の高分子物質の陀去するこず
ずにより、生成物をさらに粟補する方法に぀いお
述べる。その粟補は、䟋えばチオプロピルセフア
ロヌス6B フアルマシア瀟補で䟋瀺される
様な、チオヌル基を含有する化合物を結合する暹
脂を甚いお緩衡液䞭クロマトグラフむヌを斜行す
るこずにより成される。即ち、未粟補の反応性重
合䜓を該カラムに通すず、アミノ末端にチオヌル
含有基を含む反応性重合䜓はカラムに結合し、䞍
玔物である、チオヌル含有基を含たない重合䜓は
溶出される。次いでカラムに−メルカプト゚タ
ノヌルやゞチオスレむトヌル等の緩衡溶液を通す
ず、粟補された、チオヌル含有基を含む反応性重
合䜓が溶出する。溶出液は、酞性ずしお重合䜓を
沈柱ずするか、又は透析しお䜎分子物質を陀く。
凍結也燥を斜しお、目的物を埗るこずもできる。 次に、本発明の反応性重合䜓のうち、匏〔〕
におけるが隣りの硫黄原子ず共に掻性ゞスルフ
むド結合を圢成しうる基を衚わす堎合、即ち、䞻
鎖のアミノ末端に䞋蚘匏〔−〕 〔匏〔−〕においお、の定矩は前蚘匏
〔〕の堎合ず同じ。X1は隣りの硫黄原子ず共に
掻性ゞスルフむド結合を圢成しうる基を衚わす。〕 で衚わされる掻性基を有しおいる反応性重合䜓を
補造する方法に぀いお説明する。 その方法は、アミノ末端に前蚘匏〔−〕で
衚わされる掻性基を含有する重合䜓、即ち、チオ
ヌル基を含有する重合䜓ず、掻性ゞスルフむド化
合物を反応させる方法である。掻性ゞスルフむド
化合物ずしおは、䟋えば、−ピリゞルゞスルフ
むド
Compounds such as [Formula] in which R 1 representing a protecting group for a thiol group and R 2 representing an activating group for a carbonyl group are incorporated into the molecule can also be used in this method. The acylating agent containing a protected thiol group used for the hydrophilic polymer used in the reaction of this method is used in an amount of 1 to 100 times equivalent, more preferably 5 times to 100 times equivalent. The solvent used is a buffer solution (PH
5 to 8), solvents that form a homogeneous solution, such as DMF, are preferred. The reaction can also proceed more advantageously in the presence of a base such as triethylamine or sodium carbonate. The reaction temperature is 0°C to 50°C, preferably 4°C to 30°C.
It is ℃. Reaction time is 1 hour to 3 days. After the reaction is complete, if the reaction solution is a buffer solution, add hydrochloric acid,
The product is obtained by adding an acid such as sulfuric acid to lower the pH of the reaction solution to 4 or below, causing a precipitate of a hydrophilic polymer in which an acyl group having a protected thiol group is bonded to the amino terminal, and removing the precipitate. refine. If the reaction solution uses a solvent other than water, it can be purified in the same manner after adding a buffer solution. Alternatively, it can be purified by dialysis or gel filtration. The protecting group of the thiol group of the thus obtained hydrophilic polymer in which an acyl group having a protected thiol group is bonded to the amino terminal is removed, and the desired product, the amino terminal of the main chain, is bonded with the formula A method for obtaining a reactive polymer having an active group represented by [-a] will be described. The method for removing the protecting group is
Depends on the type of protecting group. For example, the expression []
When R 1 forms a disulfide together with the adjacent sulfur atom, a method of reductively cleaving the disulfide group is preferably used. For example, by acting on the hydrophilic polymer in an aqueous solution with a reducing agent such as 2-mercaptoethanol, dithiothreitol, or sodium borohydride, it is converted into a reactive polymer having a thiol-containing group at the amino terminal. can lead. The amount of reducing agent used is preferably 1 to 100 equivalents. Reaction temperature is 0℃~50℃,
The reaction time is preferably 1 minute to 3 hours. In formula [], when R 1 is an acyl group, it is eliminated by hydrolysis. The reaction is carried out in an aqueous solution using 1 to 100 equivalents of an alkali such as hydroxylamine, sodium carbonate, or sodium hydroxide as a catalyst. Reaction temperature is 0 to 50℃, reaction time is 10 minutes to 10 minutes.
time is preferable. When R 1 is a benzyl group in formula [], the hydrophilic polymer is treated with excess trifluoroacetic acid, methanesulfonic acid, or a mixture thereof. Reaction temperature is 0℃~30℃, reaction time is
30 minutes to 10 hours. In addition, when N-acetylhomocysteine thiolactone is used as an acylating agent containing a protected thiol group represented by formula [], the deprotecting group reaction proceeds simultaneously with the acylation reaction, so the deprotecting group is overlapped. There is no need to perform a reaction. At the amino terminal of the main chain thus obtained, the formula [
The reactive polymer having an active group represented by -a] does not contain any low-molecular substances as impurities, but it does contain a part of the hydrophilic polymer used as a raw material in an unreacted form. There is a possibility that it is. Next, a method for further purifying the product by removing this unreacted polymeric substance will be described. Its purification is accomplished by performing chromatography in a buffer using a resin that binds a compound containing a thiol group, such as thiopropyl sepharose 6B (manufactured by Pharmacia). . That is, when an unpurified reactive polymer is passed through the column, the reactive polymer containing a thiol-containing group at the amino end binds to the column, and the impurity, a polymer that does not contain a thiol-containing group, is eluted. . A buffered solution such as 2-mercaptoethanol or dithiothreitol is then passed through the column to elute the purified reactive polymer containing thiol-containing groups. The eluate is acidified to precipitate the polymer or dialyzed to remove low-molecular substances.
The desired product can also be obtained by freeze-drying. Next, among the reactive polymers of the present invention, formula []
When X in represents a group capable of forming an active disulfide bond with the adjacent sulfur atom, that is, the following formula [-a] is present at the amino terminal of the main chain: [In formula [-b], the definition of W is the same as in the above formula []. X 1 represents a group capable of forming an active disulfide bond with the adjacent sulfur atom. ] A method for producing a reactive polymer having an active group represented by the following will be explained. The method is to react a polymer containing an active group represented by the above formula [-a] at the amino terminal, that is, a polymer containing a thiol group, with an active disulfide compound. As the active disulfide compound, for example, 2-pyridyl disulfide

【匏】−ピリゞル ゞスルフむド[Formula] 4-pyridyl disulfide

【匏】 5′−ゞチオビス−ニトロ安息銙酞
[Formula] 5, 5'-dithiobis(2-nitrobenzoic acid)

【匏】−カ ルボキシ−−ピリゞルゞスルフむド −オキシ−−ピリゞルゞスルフむド
[Formula] 4-carboxy-2-pyridyl disulfide N-oxy-2-pyridyl disulfide

【匏】−ニトロプニ ルゞスルフむド[Formula] 2-nitropheni Ludisulfide

【匏】 −ニトロ−−ピリゞルゞスルフむド
[Formula] 4-nitro-2-pyridyl disulfide

【匏】−ベ ンゟチアゟむルゞスルフむド
[Formula] 2-benzothiazoyl disulfide

【匏】−ベ ンゟむミダゟむルゞスルフむド
[Formula] 2-benzimidazoyl disulfide

【匏】−フ ゚ニルアミノ−N′−プニルむミノメチルゞス
ルフむド を挙げるこずができる。 䞡者の反応は、通垞、氎又はゞメチルホルムア
ミドやゞメチルスルホキシド等の有機溶剀を反応
溶媒ずする均䞀反応系で行なわれる。あるいはた
た、重合䜓の氎溶液に掻性ゞスルフむド化合物又
はそのアセトン溶液又はゞオキサン溶液等を添加
混合した反応系で行なうこずもできる。反応枩床
は−℃〜70℃、反応時間は分〜24時間が適圓
である。 反応埌の粟補は、反応液に緩衡液を加えた埌、
酞性により重合䜓を沈柱せしめ、取する方法、
反応液を透析したのち、凍結也燥を斜行する方法
等により、容易に斜行するこずができる。 次に、しかしお埗られた䞻鎖のアミノ末端に匏
〔−〕で衚わされる掻性基を有しおいる反応
性重合䜓を、䞻鎖のアミノ末端に匏〔−〕で
衚わされる掻性基を有しおいる反応性重合䜓に倉
換する方法に぀いお述べる。その方法は、ゞスル
フむド基を還元的に切断する方法が奜たしい。甚
いられる還元剀は、䟋えば−メルカプト゚タノ
ヌル、ゞチオスレむトヌル等のチオヌル類、氎玠
化ホり玠ナトリりム、氎玠化ホり玠カルシりム等
の氎玠化ホり玠化合物等が䜿甚される。反応溶媒
は、氎、又はゞメチルホルムアミドが奜たしい。
甚いる還元剀の量は〜100圓量が奜たしい。反
応枩床は〜50℃、反応時間は分〜時間が奜
たしい。粟補は、通垞の酞による沈柱法、ゲル
過法、透析法等によりおこなう。 本発明の反応性重合䜓は、偎鎖に反応性に富ん
だ倚数のカルボキシル基又はその塩を有し、
分子末端に反応性に富んだチオヌル基又は掻性ゞ
スルフむド結合を有しおいるので、これらの基の
反応性を利甚しお、䟋えば以䞋に述べる劂き方法
で免疫グロブリンず现胞毒物を有効か぀効率良く
結合させるこずができ、埗られた結合物は、暙的
指向型の薬剀ずしお甚いるこずができる。 偎鎖に導入される现胞毒物ずしおは、䟋えば分
子䞭にアミノ基又はむミノ基を含む制ガン剀等が
甚いられる。そしお本発明の反応性重合䜓ず现胞
毒物ずの反応は、通垞、氎又はゞメチルホルムア
ミドやゞメチルスルホキシド等の有機溶剀を反応
溶媒ずする均䞀反応系で行なわれる。反応に際し
おは、䟋えば−゚チル−−−ゞメチルア
ミノプロピルカルボゞむミド塩酞塩がゞシクロ
ヘキシルカルボゞむミドで重合䜓䞭のカルボキシ
ル基を掻性化しおもよく、あるいはカルボキシル
基を混合酞無氎物の圢に掻性化しおおいおもよ
い。反応枩床は−40℃〜100℃、反応時間は10分
〜10日間が適圓である。  発明の効果 かくしお埗られた现胞毒物を偎鎖に結合した反
応性重合䜓は、分子末端になお反応性に富んだチ
オヌル基又は掻性ゞスルフむド結合を有しおいる
ので、かかる基又は結合の反応性ず、抗腫瘍免疫
グロブリン又はそのフラグメントに発生又は導入
したチオヌル基、掻性ゞスルフむド基、マレむミ
ド基等の反応性を利甚しお䞡者を結合させ、现胞
毒物の結合した本発明の反応性重合䜓を毒性郚ず
する抗腫性を有する耇合䜓を補造するこずができ
る。具䜓的に補造法ずしおは、䟋えば以䞋の劂き
方法がある。 抗腫瘍免疫グロブリンをペプシン凊理し、
Fab′の量䜓を埗、このヒンゞ郚分のゞスル
フむド結合を、䟋えばチオヌル詊薬により還元
的に切断しお分子䞭にチオヌル基を有する
Fab′を埗る。そしおチオヌル基を有する
Fab′ず、掻性ゞスルフむド結合を有する本発
明の反応性重合䜓にさらに现胞毒性物質を結合
した重合䜓を反応させ、目的ずする抗腫瘍性耇
合䜓を埗る。 抗腫瘍性免疫グロブリンに、䟋えばサクシン
むミゞル−マレむミドベンゟ゚ヌトを䜜甚す
るこずによりマレむミド基を導入した免疫グロ
ブリンに、チオヌル基を有する本発明の反応性
重合䜓にさらに现胞毒性物質を結合した重合䜓
を反応させ、目的ずする抗腫瘍性耇合䜓を埗
る。 かくしお埗られた抗腫瘍剀は、腫瘍现胞ず遞択
的に結合した腫瘍现胞に毒性を発揮するこずが期
埅されるものである。 以䞋、実斜䟋により本発明を詳述する。 実斜䟋  − アミノ末端以䞋−末端ず省略に保
護されたチオヌル基を含むアシル基を導入され
たポリ−−グルタミン酞の補造。 ポリ−−グルタミン酞のナトリりム塩平均
分子量21000226.5mgの0.1Mリン酞ナトリりム
緩衡液PH7.515ml䞭溶液に、−サクシむ
ミゞル−−ピリゞルゞチオプロピオネヌ
ト以䞋SPDPず省略する68.8mgの゚タノヌル
ml溶液を撹拌䞋、床に分けお加え、1.5時
間宀枩䞋に反応させた。反応液をセロフアン透析
チナヌブに入れ、0.01Mリン酞緩衡液PH7.5
に察しお℃で日間透析しお䜎分子物質を陀去
するず、ポリ−−グルタミン酞分子のアミノ末
端に−−ピリゞルゞチオプロピオニル基
がアミド結合により導入されお生成したゞスルフ
むド結合を有するポリ−−グルタミン酞を含有
する溶液50mlが埗られた。 − −末端にチオヌル基を有するポリ−
−グルタミン酞の補造。 −によ぀お埗られた、アミノ末端に−
−ピリゞルゞチオプロピオニル基を導入し
た、ゞスルフむド結合を有するポリ−−グルタ
ミン酞を含有する溶液50mlに、ゞチオスレむトヌ
ル17mgの0.1Mリン酞ナトリりムPH6.0緩衡液
2.0ml䞭溶液を加え、宀枩䞋に80分間反応させた。
次いで塩酞酞性ずし、生じた沈柱を遠心分離し
た。埗られたポリ−−グルタミン酞の、沈柱物
末端にチオヌル基を有するポリ−−グルタミ
ン酞ず有しないポリ−−グルタミン酞を含む。
は、0.01NHClで掗浄した。 䞀方、チオプロピルセフアロヌス6Bゲル
Thiopropyl Sepharse 6B、フアルマシア瀟
補15mlを0.1Mリン酞ナトリりムPH6.0−
1mM゚チレンゞアミンテトラ酢酞以埌EDTA
ず省略するPH6.0緩衝液40mlに分散し、埗ら
れた分散溶液に、前蚘で埗られたポリ−−グル
タミン酞を同䞀緩衡液10mlに溶解しお埗られる溶
液を加え、宀枩䞋、窒玠雰囲気䞭でゆるやかに
倜撹拌した。これで末端にチオヌル基を有するポ
リ−−グルタミン酞が暹脂に結合する。次いで
暹脂をロ別し、0.01Mリン酞緩衡液PH7.5で充分
掗浄した。 かくしお埗られた暹脂を0.1Mトリス−塩酞−
1m MEDEAPH8.5緩衡液50mlに分散し−メ
ルカプト゚タノヌル1.17を加え、宀枩䞋窒玠雰
囲気䞭で10時間ゆるやかに撹拌した。これで末端
がチオヌル基のポリ−−グルタミン酞が暹脂か
ら遊離する。 暹脂を濟別し、0.01Mトリス−塩酞−0.1m
MEDTAPH8.5緩衡液でよく掗浄し、次いで、
濟液ず掗液を氷冷䞋塩酞でPH1.8ずし、生じた末
端にチオヌル基を有するポリ−−グルタミン酞
の沈柱を遠心分離した。 − −末端に掻性ゞスルフむド基を有する
ポリ−−グルタミン酞の補造。 −で埗られた末端にチオヌル基を有する
ポリ−−グルタミン酞の沈柱を、再び0.4Mリ
ン酞ナトリりム−1mMEDTAPH7.5緩衡液
mlに溶解し、埗られた溶液を−ピリゞルゞスル
フむド以䞋−PDSず省略する23mgの゚タ
ノヌルml溶液を0.1Mリン酞ナトリりム−
1m MEDTAPH6.010mlに加えお埗られた溶液
に加え、宀枩䞋で30分間反応させた埌、ポリ−
−グルタミン酞の末端が掻性ゞスルフむド基ず
なる反応液をセロフアンチナヌブに入れ、
0.01Mリン酞ナトリりムPH7.5緩衡液に察し
お時間、玔れに察しお、日透析した。回収液
を枛圧で30mlに枛少し、凍結也燥するず、末端に
−ピリゞルゞチオ基が導入されたポリ−−グ
ルタミン酞ナトリりム塩の綿状固䜓35.4mgが
埗られた重量収率15.6。実斜䟋−の
結果から、埗られる重合䜓は末端に−ピリゞル
ゞチオ基を含有しおおり分子量は17800である。 − −末端にチオヌル基を有するポリ−
−グルタミン酞の補法。 䞀定量のサンプルを粟秀し1.895mg、3.00ml
の0.1Mリン酞ナトリりム緩衡液PH7.2に溶解
し、ゞチオスレむトヌルの小片を加え、遊離した
−メルカプトピリゞンに由来する吞収
343nm、分子吞光係数ε8080を枬定した
0.286。粟秀されたサンプル䞭の末端基量
は0.1062ÎŒmole、埓぀お、同サンプル䞭の末端掻
性ゞスルフむド含有ポリ−−グルタミン酞分子
の分子量は17800、又、同分子䞭のグルタミン酞
ナトリりム塩のナニツト数は、ナニツトの
質量数が151であるこずにより、118ず蚈算され
た。 反応埌をセフアデツクス−251.0×40cm、
0.01Mリン酞緩衡液−1m MEDTAPH6.0に通
しお䜎分子物質を陀去するず、−末端にチオヌ
ル基を有するポリ−−グルタミン酞の溶液が埗
られた。 実斜䟋  − −末端に保護されたチオヌル基を含む
アシル基を導入されたグルタミン酞ずアラニン
共重合䜓の補造。 −グルタミン酞ず−アラニンの共重合䜓の
ナトリりム平均分子量17200、グルタミン酞−
アラニン構成圓量比30.3、172mgのトリス−
塩酞緩衡液PH8.210ml䞭溶液に、−アセ
チルホモシステむンチオラクトン48mgの゚タノヌ
ルml溶液を床にわけお加え、枩床䞋で10
時間撹拌した。反応液をセロフアン透析チナヌブ
に入れ、1m MEDTA−0.01Mリン酞緩衡液PH
6.0に察しお℃で日間透析し、䜎分子物質
を陀くず、−グルタミン酞ず−アラニンの共
重合䜓のアミノ末端に、−アセチルホモシステ
むンがアミド結合により導入されお生成した、チ
オヌル基を有する重合䜓を含有する溶液16mlが埗
られた。 実斜䟋−で瀺したず同じ方法、即ち、チ
オプロピルセフアロヌス6Bゲルにチオヌル基が
導入された重合䜓をい぀たん結合し、チオヌル基
が導入されなか぀た、未反応重合䜓を陀き、次い
でチオヌル基が導入された重合䜓をゲルから溶出
する方法によ぀おチオヌル基を有する重合䜓の粟
補品を埗た沈柱物。 − −末端に掻性ゞスルフむド基を有する
−グルタミン酞ず−アラニンの共重合䜓の
補造。 −で埗られた、末端にチオヌル基を有す
る−グルタミン酞ず−アラニンの共重合䜓の
沈柱に、再び0.4Mリン酞緩衡液−1m MEDTA
PH7.5mlを加えお溶解し、埗られた溶液に、
実斜䟋−ず同様に−PDSを加えお反応
せしめ、さらに透析、凍結也燥の凊理工皋を斜し
お、目的物である、末端に−ピリゞルゞチオ基
が導入された−グルタミン酞ず−アラニンの
共重合䜓ナトリりム塩の綿状固䜓を22.4mgを
埗た重量収率13。実斜䟋−の結果か
ら、埗られた重合䜓は末端に−ピリゞルゞチオ
基を含有しおおり、分子量は13900である。 − −末端にチオヌル基を有する−グル
タミン酞ず−アラニンの共重合䜓の補造。 2.2で埗られた末端に−ピリゞルゞチオ基
を含有する重合䜓1.154mgを粟秀し、実斜䟋−
ず同様に、ゞチオスレむトヌルず反応せしめ
た。遊離した−メルカプトピリゞンに由来する
吞収を枬定しお、同サンプル䞭の末端掻性基量、
重合䜓の分子量を算出した。末端掻性基量
0.083ÎŒmole、分子量13900。 反応液を0.01Mリン酞緩衡液−1m MEDTA
PH6.0に透析しお、䜎分子物質を陀くず、−
末端にチオヌル基を有する−グルタミン酞ず
−アラニンの共重合䜓の溶液が埗られた。 実斜䟋  − −末端にチオヌル基を含むポリ−−
グルタミン酞の補造。 ポリ−−グルタミン酞のナトリりム塩平均
分子量17000170mgを0.1Mリン酞ナトリりム緩
衡液PH7.3mlに溶解し、−アセチルメル
カプト無氎コハク酞346mgをゞメチルホルムアミ
ド2.0mlに溶解したものを回にわけお加え、PH
を7.0〜7.5の間に保ち぀぀、宀枩䞋に時間撹拌
した。次いで反応液をセロフアン透析チナヌブに
入れ、0.01Mリン酞緩衡液PH7.5に察しお
℃で充分透析した。回収液8.5ml。0.5Mヒドロキ
シルアミン溶液2.5mlを加え、30℃にお30分間反
応せしめ、チオヌル基を保護しおいるアセチル基
を脱離せしめた。℃にお反応液に1NHClを加
えおPHを2.0ずし、時間攟眮したのち、生じた
沈柱を遠心分離するず、−末端にチオヌル基が
導入されたポリ−−グルタミン酞の沈柱が埗ら
れた。 さらに−で瀺したず同じ方法、即ちチオ
プロピルセフアロヌス6Bゲルにチオヌル基が導
入された重合䜓をい぀たん結合し、チオヌル基が
導入されなか぀た未反応の重合䜓を陀き、次いで
チオヌル基が導入された重合䜓をゲルより溶出せ
しめる方法により、チオヌル基を有する重合䜓の
粟補品を埗、塩酞酞性により沈柱物ずしお埗た。 − −末端に掻性ゞスルフむド基を有する
ポリ−−グルタミン酞の補造。 −で埗られた、末端にチオヌル基を有す
るポリ−−グルタミン酞の沈柱を、再び0.4M
リン酞ナトリりム−1m MEDTA緩衡液PH7.6
mlにずかし、これに5′−ゞチオビス−
ニトロ安息銙酞39.6mgを加えお溶解し、30分間
反応せしめた。反応液にセロフアンチナヌブに入
れ、℃にお氎に察しお充分透析した。回収液を
凍結也燥するず、目的物である、−ニトロ−
−カルボキシプニルゞチオ基を䞻鎖に−末端
に含有するポリ−−グルタミン酞ナトリりム
塩の綿状固䜓29.6mgが埗られた重量収率17.4
。実斜䟋3.3の結果から、埗られた重合䜓
は、末端に−ニトロ−−カルボキシプニル
ゞチオ基を含有しおおり、分子量は14900である。 − −末端にチオヌル基を有するポリ−
−グルタミン酞の補造。 −で埗られた、末端に−ニトロ−−
カルボキシプニルゞチオ基を含有しおいる重合
䜓2.208mgを粟秀し、0.1Mリン酞緩衡液3.00mlに
溶解した。10mM2−メルカプト゚タノヌル0.10
mlを加え、30分間攟眮した埌、遊離した−メル
カプト−−ニトロ安息銙酞に由来する412nmに
おける吞収ε12000を枬定し、末端掻性基
量を定量し、重合䜓の分子量を算出した。末端掻
性基量0.148ÎŒmole、分子量14900。 反応液を0.01Mリン酞緩衡液−1m MEDTA
PH5.8に透析しお、䜎分子物質を陀くず、−
末端にチオヌル基を有するポリ−−グルタミン
酞の溶液が埗られた。
[Formula] N-phenylamino-N'-phenyliminomethyl disulfide can be mentioned. Both reactions are usually carried out in a homogeneous reaction system using water or an organic solvent such as dimethylformamide or dimethyl sulfoxide as a reaction solvent. Alternatively, the reaction can be carried out using a reaction system in which an active disulfide compound or its acetone solution, dioxane solution, etc. are added to and mixed with an aqueous solution of the polymer. The reaction temperature is -5°C to 70°C, and the reaction time is suitably 1 minute to 24 hours. For purification after the reaction, add a buffer to the reaction solution,
A method for precipitating and removing a polymer with acidity,
This can be easily carried out by dialysis of the reaction solution and then freeze-drying. Next, the reactive polymer having the active group represented by the formula [-b] at the amino end of the main chain is added to the amino end of the main chain, and the reactive polymer having the active group represented by the formula [-a] is added to the amino end of the main chain. A method for converting the compound into a reactive polymer having a group will be described. Preferably, the method is one in which the disulfide group is reductively cleaved. Examples of the reducing agent used include thiols such as 2-mercaptoethanol and dithiothreitol, and borohydride compounds such as sodium borohydride and calcium borohydride. The reaction solvent is preferably water or dimethylformamide.
The amount of reducing agent used is preferably 1 to 100 equivalents. The reaction temperature is preferably 0 to 50°C and the reaction time is preferably 1 minute to 3 hours. Purification is carried out by conventional acid precipitation, gel filtration, dialysis, etc. The reactive polymer of the present invention has a large number of highly reactive carboxyl groups (or salts thereof) in the side chain,
Since it has a highly reactive thiol group or active disulfide bond at the end of the molecule, the reactivity of these groups can be used to effectively and efficiently bind immunoglobulins and cytotoxins, for example, by the method described below. The resulting conjugate can be used as a targeted drug. As the cytotoxic substance introduced into the side chain, for example, an anticancer agent containing an amino group or an imino group in the molecule is used. The reaction between the reactive polymer of the present invention and the cytotoxic substance is usually carried out in a homogeneous reaction system using water or an organic solvent such as dimethylformamide or dimethyl sulfoxide as a reaction solvent. In the reaction, for example, 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride may be used to activate the carboxyl groups in the polymer with dicyclohexylcarbodiimide, or the carboxyl groups may be activated in the form of a mixed acid anhydride. You may also leave it as Appropriate reaction temperature is -40°C to 100°C and reaction time is 10 minutes to 10 days. e Effects of the invention The reactive polymer thus obtained with a cytotoxic substance bound to its side chain still has a highly reactive thiol group or active disulfide bond at the molecular end, so the reaction of such a group or bond is difficult. The reactive polymer of the present invention to which a cytotoxic agent is bound can be obtained by bonding the anti-tumor immunoglobulin or its fragment by utilizing the reactivity of the thiol group, active disulfide group, maleimide group, etc. generated or introduced into the anti-tumor immunoglobulin or its fragment. It is possible to produce a complex having antitumor properties in which the toxic portion is used. Specific manufacturing methods include, for example, the following methods. Antitumor immunoglobulin was treated with pepsin,
A dimer of Fab' is obtained, and the disulfide bond at the hinge portion is reductively cleaved using, for example, a thiol reagent to have a thiol group in the molecule.
Obtain Fab′. and has a thiol group
Fab' is reacted with the reactive polymer of the present invention having an active disulfide bond and a polymer further bound to a cytotoxic substance to obtain the desired antitumor complex. An antitumor immunoglobulin into which a maleimide group has been introduced by, for example, acting with succinimidyl m-maleimidobenzoate is reacted with a polymer in which a cytotoxic substance is further bonded to the reactive polymer of the present invention having a thiol group. to obtain the desired antitumor conjugate. The antitumor agent thus obtained is expected to exert toxicity on tumor cells to which it selectively binds. Hereinafter, the present invention will be explained in detail with reference to Examples. Example 1 1-1 Production of poly-L-glutamic acid into which an acyl group containing a protected thiol group is introduced at the amino terminal (hereinafter abbreviated as N-terminus). To a solution of 226.5 mg of sodium salt of poly-L-glutamic acid (average molecular weight 21000) in 0.1 M sodium phosphate buffer (PH 7.5) (15 ml) was added N-succiimidyl 3-(2-pyridyldithio) propionate (hereinafter referred to as A solution of 68.8 mg (abbreviated as SPDP) in ethanol (6 ml) was added in two portions under stirring, and the mixture was allowed to react at room temperature for 1.5 hours. Place the reaction solution in a cellophane dialysis tube and add 0.01M phosphate buffer (PH7.5).
When low-molecular substances are removed by dialysis at 4°C for 2 days against poly-L-glutamic acid, a 3-(2-pyridyldithio)propionyl group is introduced into the amino terminal of the poly-L-glutamic acid molecule through an amide bond, resulting in a disulfide bond. 50 ml of a solution containing poly-L-glutamic acid were obtained. 1-2 Poly-L having a thiol group at the N-terminus
- Production of glutamic acid. 1-1), 3-
Add 17 mg of dithiothreitol to 50 ml of a solution containing poly-L-glutamic acid with a disulfide bond into which a (2-pyridyldithio)propionyl group has been introduced and a 0.1 M sodium phosphate (PH6.0) buffer solution.
A 2.0 ml solution was added, and the mixture was allowed to react at room temperature for 80 minutes.
The mixture was then acidified with hydrochloric acid, and the resulting precipitate was centrifuged. Precipitate of the obtained poly-L-glutamic acid (contains poly-L-glutamic acid with and without a thiol group at the end)
was washed with 0.01NHCl. Meanwhile, 15 ml of Thiopropyl Sepharose 6B gel (manufactured by Pharmacia) was mixed with 0.1 M sodium phosphate (PH6.0).
1mM ethylenediaminetetraacetic acid (hereinafter EDTA)
(abbreviated as ) (PH6.0) buffer solution, and to the obtained dispersion solution, a solution obtained by dissolving the poly-L-glutamic acid obtained above in 10 ml of the same buffer solution was added, and the solution was heated to room temperature. 1 in a nitrogen atmosphere.
Stirred overnight. This binds poly-L-glutamic acid having a thiol group at the end to the resin. The resin was then filtered and thoroughly washed with 0.01M phosphoric acid buffer pH 7.5. The thus obtained resin was diluted with 0.1M Tris-hydrochloric acid.
The mixture was dispersed in 50 ml of 1m MEDEA (PH8.5) buffer solution, 1.17 g of 2-mercaptoethanol was added, and the mixture was gently stirred at room temperature in a nitrogen atmosphere for 10 hours. As a result, poly-L-glutamic acid having a thiol group at the end is released from the resin. Filter the resin and add 0.01M Tris-HCl-0.1m
Wash thoroughly with MEDTA (PH8.5) buffer, then
The filtrate and washing solution were adjusted to pH 1.8 with hydrochloric acid under ice-cooling, and the resulting precipitate of poly-L-glutamic acid having a thiol group at its terminal was centrifuged. 1-3 Production of poly-L-glutamic acid having an active disulfide group at the N-terminus. The precipitate of poly-L-glutamic acid having a thiol group at the end obtained in step 1-2) was added to the 0.4M sodium phosphate-1mMEDTA (PH7.5) buffer solution 1 again.
A solution of 23 mg of 2-pyridyl disulfide (hereinafter abbreviated as 2-PDS) in ethanol (4 ml) was dissolved in 0.1 M sodium phosphate.
Add to the resulting solution by adding 10 ml of 1m MEDTA (PH6.0) and react for 30 minutes at room temperature.
Put the reaction solution (the terminal of L-glutamic acid becomes an active disulfide group) into a cellophane tube,
Dialysis was performed against 0.01M sodium phosphate (PH7.5) buffer for 6 hours and against pure for 1 day. The recovered liquid was reduced to 30 ml under reduced pressure and freeze-dried to obtain 35.4 mg of a flocculent solid of poly-L-glutamic acid (sodium salt) with a 2-pyridyldithio group introduced at its terminal (weight yield 15.6%). ). From the results of Example 1-4), the obtained polymer contains a 2-pyridyldithio group at the end and has a molecular weight of 17,800. 1-4 Poly-L having a thiol group at the N-terminus
-Process for producing glutamic acid. Accurately weigh a certain amount of sample (1.895mg) and 3.00ml
A small piece of dithiothreitol was added to the solution in 0.1M sodium phosphate buffer (PH7.2), and the absorption (343 nm, molecular extinction coefficient ε = 8080) derived from liberated 2-mercaptopyridine was measured ( A=0.286). The amount of terminal groups in the accurately weighed sample is 0.1062 Όmole. Therefore, the molecular weight of the terminal active disulfide-containing poly-L-glutamic acid molecule in the same sample is 17800, and the number of units of glutamic acid (sodium salt) in the same molecule is was calculated to be 118 since the mass number of one unit is 151. After the reaction, transfer to Cephadex G-25 (1.0 x 40 cm,
When low-molecular substances were removed by passing through 0.01M phosphoric acid buffer - 1m MEDTA (PH6.0)), a solution of poly-L-glutamic acid having a thiol group at the N-terminus was obtained. Example 2 2-1 Production of a glutamic acid and alanine copolymer into which an acyl group containing a protected thiol group is introduced at the N-terminus. Sodium copolymer of L-glutamic acid and L-alanine (average molecular weight 17200, glutamic acid-
Alanine constituent equivalent ratio 30.3:1), 172 mg Tris-
A solution of 48 mg of N-acetyl homocysteine thiolactone in ethanol (4 ml) was added in two portions to a solution in hydrochloric acid buffer (PH8.2) (10 ml), and the mixture was heated for 10 min at room temperature.
Stir for hours. Pour the reaction solution into a cellophane dialysis tube and dilute with 1m MEDTA-0.01M phosphate buffer (PH
6.0) at 4°C for 2 days to remove low-molecular substances, N-acetylhomocysteine was introduced into the amino terminal of the copolymer of L-glutamic acid and L-alanine through an amide bond. , 16 ml of a solution containing a polymer having thiol groups was obtained. The same method as shown in Example 1-2) was used, that is, the polymer into which a thiol group had been introduced was once bonded to the thiopropyl Sepharose 6B gel, and the unreacted polymer into which no thiol group had been introduced was removed. Next, a purified product of a polymer having a thiol group was obtained by eluting the polymer having a thiol group from the gel (precipitate). 2-2 Production of a copolymer of L-glutamic acid and L-alanine having an active disulfide group at the N-terminus. To the precipitate of the copolymer of L-glutamic acid and L-alanine having a thiol group at the end obtained in 2-1), add 0.4M phosphoric acid buffer and 1m MEDTA again.
(PH7.5) Add and dissolve 2 ml, and to the resulting solution,
2-PDS was added and reacted in the same manner as in Example 1-2), and further treatment steps of dialysis and freeze-drying were performed to obtain the target product, L-glutamic acid with a 2-pyridyldithio group introduced at the end. 22.4 mg of a flocculent solid of L-alanine copolymer (sodium salt) was obtained (weight yield: 13%). From the results of Example 2-3), the obtained polymer contains a 2-pyridyldithio group at the end and has a molecular weight of 13,900. 2-3 Production of a copolymer of L-glutamic acid and L-alanine having a thiol group at the N-terminus. 1.154 mg of the polymer containing a 2-pyridyldithio group at the end obtained in 2.2) was accurately weighed, and Example 1-
It was reacted with dithiothreitol in the same manner as in 4). By measuring the absorption derived from liberated 2-mercaptopyridine, the amount of terminal active groups in the same sample,
The molecular weight of the polymer was calculated. Terminal active group amount
0.083ÎŒmole, molecular weight 13900. The reaction solution was mixed with 0.01M phosphate buffer - 1m MEDTA.
(PH6.0) to remove low molecular weight substances, N-
L-glutamic acid with a thiol group at the end and L
- A solution of a copolymer of alanine was obtained. Example 3 3-1 Poly-L- containing a thiol group at the N-terminus
Production of glutamic acid. 170 mg of sodium salt of poly-L-glutamic acid (average molecular weight 17000) was dissolved in 5 ml of 0.1 M sodium phosphate buffer (PH7.3), and 346 mg of S-acetylmercaptosuccinic anhydride was dissolved in 2.0 ml of dimethylformamide. Add in two times and adjust the pH
While maintaining the temperature between 7.0 and 7.5, the mixture was stirred at room temperature for 2 hours. Next, the reaction solution was placed in a cellophane dialysis tube and diluted with 0.01M phosphate buffer (PH7.5).
It was thoroughly dialyzed at ℃. 8.5ml of recovery liquid. 2.5 ml of 0.5M hydroxylamine solution was added and reacted at 30°C for 30 minutes to remove the acetyl group protecting the thiol group. 1NHCl was added to the reaction solution at 0°C to adjust the pH to 2.0, and after standing for 2 hours, the resulting precipitate was centrifuged to obtain a precipitate of poly-L-glutamic acid with a thiol group introduced at the N-terminus. Ta. Furthermore, using the same method as shown in 1-2), that is, the polymer into which thiol groups have been introduced is bonded to the thiopropyl Sepharose 6B gel, the unreacted polymer into which thiol groups have not been introduced is removed, and then the thiol A purified product of a polymer having a thiol group was obtained by eluting the polymer into which the group had been introduced from the gel, and a precipitate was obtained by acidifying with hydrochloric acid. 3-2 Production of poly-L-glutamic acid having an active disulfide group at the N-terminus. The precipitate of poly-L-glutamic acid having a thiol group at the end obtained in 3-1) was added to 0.4M again.
Sodium phosphate - 1m MEDTA buffer (PH7.6)
Dissolve to 2 ml and add 5,5'-dithiobis(2-
39.6 mg of nitrobenzoic acid) was added and dissolved, and the mixture was allowed to react for 30 minutes. The reaction solution was poured into a cellophane tube and thoroughly dialyzed against water at 4°C. When the recovered liquid is freeze-dried, the target product, 4-nitro-3
-29.6 mg of a flocculent solid of poly-L-glutamic acid (sodium salt) containing a carboxyphenyl dithio group at the N-terminus in the main chain was obtained (weight yield 17.4
%). From the results of Example 3.3), the obtained polymer contains a 4-nitro-3-carboxyphenyldithio group at the end and has a molecular weight of 14,900. 3-3 Poly-L having a thiol group at the N-terminus
- Production of glutamic acid. 3-2), with 4-nitro-3- at the end
2.208 mg of a polymer containing carboxyphenyl dithio groups was accurately weighed and dissolved in 3.00 ml of 0.1M phosphoric acid buffer. 10mM2-Mercaptoethanol 0.10
ml and left for 30 minutes, the absorption at 412 nm (ε = 12000) derived from liberated 5-mercapto-2-nitrobenzoic acid was measured, the amount of terminal active groups was quantified, and the molecular weight of the polymer was calculated. did. Terminal active group amount 0.148Όmole, molecular weight 14900. The reaction solution was mixed with 0.01M phosphate buffer - 1m MEDTA.
(PH5.8) to remove low molecular weight substances, N-
A solution of poly-L-glutamic acid having a thiol group at the end was obtained.

Claims (1)

【特蚱請求の範囲】  構成単䜍の60モル以䞊が匏で衚わさ
れる構成単䜍からなり、 〔匏においお、は氎玠原子又は䟡の
陜むオンを衚わす。は〜の敎数を衚わす。〕 匏の構成単䜍が100モルでないずき、
残りの構成単䜍は、匏′ 〔匏′においお、は−−CH3
【匏】たたは−CH2OHで衚わされ る基である。〕 で衚わされる構成単䜍からなり、重合床が〜
3000の芪氎性重合䜓に、匏 R1S−−CO−R2  〔〕 〔匏䞭、は炭玠数〜のアルキレン基を衚
わす。R1はチオヌル基の保護基を衚わす。R2は
隣接するカルボニル基を掻性化し埗る基を衚わ
す。〕 で衚わされる、保護されたチオヌル基を含有する
アシル化剀を反応せしめ、次いでチオヌル基の保
護基を陀去するこずを特城ずする、構成単䜍の60
モル以䞊が匏で衚わされる構成単䜍から
なり、 〔匏においお、は氎玠原子又は䟡の
陜むオンを衚わす。は〜の敎数を衚わす。〕 匏の構成単䜍が100モルでないずき、
残りの構成単䜍は、匏′ 〔匏′においお、は−−CH3
【匏】たたは−CH2OHで衚わされ る基である。〕 で衚わされる構成単䜍からなり、そしお䞻鎖のア
ミノ末端に匏〔−〕で衚わされる掻性基を有
しおいる、 〔匏−においお、の定矩は前蚘匏
の堎合ず同じ。〕 重合床が〜3000の反応性重合䜓の補造法。  構成単䜍の60モル以䞊が匏で衚わさ
れる構成単䜍からなり、 〔匏においお、は氎玠原子又は䟡の
陜むオンを衚わす。は−の敎数を衚わす。〕 匏の構成単䜍が100モルでないずき、
残りの構成単䜍は、匏′ 〔匏′においお、は−−CH3
【匏】たたは−CH2OHで衚わされ る基である。〕 で衚わされる構成単䜍からなり、そしお䞻鎖のカ
ルボキシル末端に匏−で衚わされる掻性
基を有しおいる、 〔匏−においお、は炭玠数〜の
アルキレン基を衚わす。X1は隣りの硫黄原子ず
共に掻性ゞスルフむド結合を圢成しうる基を衚わ
す。〕 で衚わされる掻性基を有しおいる、重合床が〜
3000の反応性重合䜓のゞスルフむド結合を還元的
に切断するこずを特城ずする、構成単䜍の60モル
以䞊が匏で衚わされる構成単䜍からな
り、䞻鎖のアミノ末端に匏〔−〕で衚わされ
る掻性基を有しおいる、重合床が〜3000の反応
性重合䜓の補造法。 〔匏−においお、の定矩は前蚘匏
−の堎合ず同じ。〕
[Scope of Claims] 1 60 mol% or more of the structural units consist of structural units represented by the formula [], [In formula [], Z represents a hydrogen atom or a monovalent cation. m represents an integer from 1 to 4. ] When the constituent units of formula [] are not 100 mol%,
The remaining structural units are expressed by the formula [′] [In formula ['], R is -H, -CH 3 ,
It is a group represented by [Formula] or -CH 2 OH. ] Consisting of the structural unit represented by
3000 hydrophilic polymer, the formula [] R 1 S-W-CO-R 2 ... [] [In the formula, W represents an alkylene group having 1 to 4 carbon atoms. R 1 represents a protecting group for a thiol group. R 2 represents a group capable of activating an adjacent carbonyl group. ] 60 of the structural unit characterized by reacting with an acylating agent containing a protected thiol group, and then removing the protecting group of the thiol group.
At least mol% consists of the structural unit represented by the formula [ ], [In formula [], Z represents a hydrogen atom or a monovalent cation. m represents an integer from 1 to 4. ] When the constituent units of formula [] are not 100 mol%,
The remaining structural units are expressed by the formula [′] [In formula ['], R is -H, -CH 3 ,
It is a group represented by [Formula] or -CH 2 OH. ] Consisting of a structural unit represented by the following, and having an active group represented by the formula [-a] at the amino terminal of the main chain, [In formula [-a], the definition of W is the same as in the above formula []. ] A method for producing a reactive polymer having a degree of polymerization of 5 to 3000. 2 60 mol% or more of the structural units consist of structural units represented by the formula [], [In formula [], Z represents a hydrogen atom or a monovalent cation. m represents an integer of 1-4. ] When the constituent units of formula [] are not 100 mol%,
The remaining structural units are expressed by the formula [′] [In formula ['], R is -H, -CH 3 ,
It is a group represented by [Formula] or -CH 2 OH. ] Consisting of a structural unit represented by the following, and having an active group represented by the formula [-b] at the carboxyl terminal of the main chain, [In formula [-b], W represents an alkylene group having 1 to 4 carbon atoms. X 1 represents a group capable of forming an active disulfide bond with the adjacent sulfur atom. ] Having an active group represented by
3000 is characterized by reductively cleaving the disulfide bonds of the reactive polymer, in which 60 mol% or more of the structural units are structural units represented by the formula [], and the amino terminal of the main chain has the formula [-a ] A method for producing a reactive polymer having an active group represented by the following and having a degree of polymerization of 5 to 3,000. [In formula [-a], the definition of W is the same as in the above formula [-b]. ]
JP3295683A 1983-03-02 1983-03-02 Reactive polymer and its production Granted JPS59159828A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP3295683A JPS59159828A (en) 1983-03-02 1983-03-02 Reactive polymer and its production

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3295683A JPS59159828A (en) 1983-03-02 1983-03-02 Reactive polymer and its production

Publications (2)

Publication Number Publication Date
JPS59159828A JPS59159828A (en) 1984-09-10
JPH0149299B2 true JPH0149299B2 (en) 1989-10-24

Family

ID=12373375

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3295683A Granted JPS59159828A (en) 1983-03-02 1983-03-02 Reactive polymer and its production

Country Status (1)

Country Link
JP (1) JPS59159828A (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9007384D0 (en) * 1990-04-02 1990-05-30 Duncan Ruth Coupling between polymers and other organic molecular entities utilising thiol-specific reactive groups
CA2656077C (en) * 2006-06-15 2014-12-09 Marc Mckennon A process for the preparation of poly-alpha-glutamic acid and derivatives thereof
GB2509972A (en) * 2013-01-21 2014-07-23 Gm Global Tech Operations Inc Shift mechanism with shift finger having a damping member
US10077323B2 (en) * 2015-07-24 2018-09-18 Bridgestone Corporation Polymers functionalized with imine compounds containing a protected thiol group

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5718727A (en) * 1980-07-07 1982-01-30 Teijin Ltd Reactive polymer and its preparation
JPS5730724A (en) * 1980-07-31 1982-02-19 Teijin Ltd Polymer having disulfide bond in molecule and its preparation

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5718727A (en) * 1980-07-07 1982-01-30 Teijin Ltd Reactive polymer and its preparation
JPS5730724A (en) * 1980-07-31 1982-02-19 Teijin Ltd Polymer having disulfide bond in molecule and its preparation

Also Published As

Publication number Publication date
JPS59159828A (en) 1984-09-10

Similar Documents

Publication Publication Date Title
AU723442B2 (en) Method for preparing drug complex
US4385169A (en) Reactive alpha amino acid polymer
AU723392B2 (en) Drug complex
US5548064A (en) Vitamin B12 conjugates with EPO, analogues thereof and pharmaceutical compositions
JPH064678B2 (en) Method for producing antibody complex
JPH048411B2 (en)
US5738864A (en) Drug delivery agents incorporating mitomycin
JPH0149299B2 (en)
EP3166644B1 (en) Method of synthesising adcs using photocleavable linkers on solid support
WO1991015242A1 (en) Conjugate compounds of polymers with other organic molecular entities
JPS6238368B2 (en)
JPH0149298B2 (en)
JPS6219770B2 (en)
Veronese et al. Preparation and properties of monomethoxypoly (ethylene glycol)-modified enzymes for therapeutic applications
Palacios et al. Novel solid-phase synthesis of thiol-terminated-poly (α-amino acid)-drug conjugate
JPH0338294B2 (en)
WO1987004171A1 (en) Process for preparing antibody complex
AU2002255172B2 (en) Soluble protein-polymer systems for drug delivery
JPS60168726A (en) Cytotoxic substance-bound reactive polymer and its production
JPH10509208A (en) Functionalized polymers for site-specific binding
JPS6238369B2 (en)
JPS6119635A (en) Cytotoxic substance and protein complex
VERONESE et al. and L. SARTORE
JPH0428000B2 (en)
JPH029564B2 (en)